Chronic glaucoma case finding and treatment in rural Africa: some questions and answers.

Chronic glaucoma case finding and treatment in rural Africa: some questions and answers. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Chronic glaucoma case finding and treatment in rural Africa: some questions and answers. Abstract Text:

C Cook,

Chronic glaucoma case finding and treatment in rural Africa: some questions and answers. Publishing Authors By Initials

C Cook,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Chronic glaucoma case finding and treatment in rural Africa: some questions and answers. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Community eye health / International Centre for Ey

VOLUME: 14

Page Numbers: 43-4

Journal Abbreviation:

ISSN: 0953-6833

DAY: 11

MONTH: 05

YEAR: 2001

Chronic glaucoma case finding and treatment in rural Africa: some questions and answers. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8912615

Chronic glaucoma case finding and treatment in rural Africa: some questions and answers. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Chronic glaucoma case finding and treatment in rural Africa: some questions and answers. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Chronic glaucoma case finding and treatment in rural Africa: some questions and answers.

AFFILIATION: KwaZulu-Natal Blindness, Prevention Programme, PO Box 899, Hilton 3245, South Africa.

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Community Eye Health

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Chronic glaucoma case finding and treatment in rural Africa: some questions and answers Related Publications

• 449.
• 5-HTTLPR Genotype-Specific Phenotype in Children and Adolescents With Autism.
• A proposed proton shuttle mechanism for saccharopine dehydrogenase from Saccharomyces cerevisiae.
• A prospective, open-label trial of memantine in the treatment of cognitive, behavioral, and memory dysfunction in pervasive developmental disorders.
• An intracrine view of angiogenesis.
• Association of dopamine transporter genotype with disruptive behavior disorders in an eight-year longitudinal study of children and adolescents.
• Association of the oxytocin receptor gene (OXTR) in Caucasian children and adolescents with autism.
• Beta-arrestins 1 and 2 differentially regulate LPS-induced signaling and pro-inflammatory gene expression.
• Characterization and in vitro degradation of salicylate-derived poly(anhydride-ester microspheres).
• Chronic glaucoma case finding and treatment in rural Africa: some questions and answers.
• Complete kinetic mechanism of homoisocitrate dehydrogenase from Saccharomyces cerevisiae.
• Conformational analysis of the cis- and trans-adducts of the Pictet - Spengler reaction. Evidence for the structural basis for the C(1) - N(2) scission process in the cis- to trans-isomerization.
• Differential regulation of lipopolysaccharide and Gram-positive bacteria induced cytokine and chemokine production in splenocytes by Galphai proteins.
• Effect of Medicaid Managed Care on racial disparities in health care access.
• First enantiospecific total synthesis of the important biogenetic intermediates, (+)-polyneuridine and (+)-polyneuridine aldehyde, as well as 16-epi-vellosimine and macusine A.
• Genes expressed by both mesangial cells and bone marrow-derived cells underlie genetic susceptibility to crescentic glomerulonephritis in the rat.
• How to improve the outcome of cataract surgery.
• ITGB3 shows genetic and expression interaction with SLC6A4.
• Improving point predictions of random effects for subjects at high risk.
• Imputation strategies for blood pressure data nonignorably missing due to medication use.
• Monitoring cataract surgical outcomes: 'hand written' registration method.
• Oxidation artifacts in the electrospray mass spectrometry of Abeta Peptide.
• Pharmacological studies with a nonpeptidic, delta-opioid (-)-(1R,5R,9R)-5,9-dimethyl-2'-hydroxy-2-(6-hydroxyhexyl)-6,7-benzomorphan hydrochloride ((-)-NIH 11082).
• Preventing alcohol-exposed pregnancies.
• Remarkably mild and efficient intramolecular Friedel-Crafts cyclization catalyzed by In(III).
• The effects of dietary protein on age and weight at the onset of puberty in Brown Swiss and Zebu heifers in the tropics.
• The molecular mechanisms responsible for resistance in plant-pathogen interactions of the gene-for-gene type function more broadly than previously imagined.
• Tremor/ataxia syndrome and fragile X premutation: diagnostic caveats.
• Walking stride variability on different walking surfaces: 849: june 1 2:00 PM - 2:15 PM.
• rasiRNAs, DNA damage, and embryonic axis specification.